139 results
Page 4 of 7
8-K
EX-99.2
eub3fl2l 6hyoj6
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.5
4mye5j463 toq
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.3
dlw5b9 rujx
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.1
u22p5rl7
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.1
tmrsc25jad8kg
23 Apr 12
BioTime Demonstrates Efficient Method for the Manufacture of Cartilage-Producing Cells from Human Embryonic Stem Cells
12:00am
8-K
EX-99.1
tyn7rsb8
20 Apr 12
Other Events
12:00am
8-K
EX-99.1
wh6xuvi ttar8vyam0x
18 Apr 12
BioTime CEO Michael D. West to Present at the Future Leaders in the Biotech Industry Conference
12:00am
8-K
EX-99.1
gvsrxbq jl
16 Apr 12
BioTime CEO Michael D. West to Present at the 8th GTC Stem Cell Summit 2012
12:00am
8-K
EX-99.1
8h4yxwog
12 Apr 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ekb9t5toifjk a6
22 Mar 12
BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTM
12:00am
8-K
EX-99.1
gimvbx
21 Mar 12
BioTime CEO Michael D. West to Present at 2012 Maxim Group Growth Conference
12:00am
8-K
EX-99.1
zeo1k
14 Mar 12
BioTime Announces Fourth Quarter and Fiscal Year End 2011 Financial Results and Recent Corporate Accomplishments
12:00am
8-K
EX-99.1
o8h67misuum md
9 Mar 12
BioTime to Present at ROTH 24th Annual Growth Stock Conference
12:00am
8-K
EX-99.1
dqtcad0boqn3oy
17 Feb 12
BioTime CEO Michael D. West to Present at New York Stem Cell Summit
12:00am
8-K
EX-99.1
1sjjdp5
24 Jan 12
Other Events
12:00am
8-K
EX-99.1
zd4b3m 08gmpm4i1
3 Jan 12
Other Events
12:00am
8-K
EX-99.1
bc9ni 8jypwx80sc7pd
21 Dec 11
BioTime Signs Agreement with USCN Life Science to Source Antibody-Based Products
12:00am
8-K
EX-99.1
g5fq0
16 Dec 11
BioTime’s Subsidiary OncoCyte Corporation Announces Plans for the Novel Pan-Cancer Diagnostic Product PanC-DxTM
12:00am
8-K
EX-99.1
1484i7rvm
12 Dec 11
BioTime Successfully Completes HyStem®-Rx Preclinical ISO 10993 Studies
12:00am